|
|
| Quarterly Results |
|
| Natco Pharma Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : G S Murthy | | Home : Natco | Book Value: 284.4746621 | | BSE Code : 524816 | Market Cap: 18509.21 | | NSE Code : NATCOPHARM | P / E : 15.28 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 625.30 | 930.50 | 1048.30 | 781.20 | | Other Income | 29.50 | 24.70 | 14.60 | 17.50 | | Total Income | 654.80 | 955.20 | 1062.90 | 798.70 | | Total Expenditure | 387.00 | 488.20 | 544.60 | 453.50 | | Operating Profit | 267.80 | 467.00 | 518.30 | 345.20 | | Interest | 3.80 | 3.00 | 3.20 | 1.20 | | Gross Profit | 264.00 | 464.00 | 515.10 | 344.00 | | Depreciation | 40.40 | 40.00 | 39.90 | 37.60 | | Tax | 42.10 | 75.30 | 83.80 | 49.90 | | Deferred Tax | -10.50 | -11.50 | -13.90 | 2.40 | | Reported Profit After Tax | 192.00 | 360.20 | 405.30 | 254.10 |
|
|
|
|
|